Please click here to download the model.
MVI-Net: This study proposed a combined deep learning model (CDLM) for microvascular invasion (MVI) prediction in hepatocellular carcinoma. This model is designed based on the ResNet18 and utilized transfer learning to initialize the first 14 convolutional layers of the model. We trained the CDLMEOB-MRI model in 987 MR images from 329 hepatocellular carcinoma patients in two hospital, and validated its performance in another independent hospital including 166 patients. We trained the CDLM CE-CT model in 918 CT images from 306 hepatocellular carcinoma patients in two hospital, and validated its performance in another independent hospital including 115 patients.
The CDLMEOB-MRI model achieved encouraging predictive performance in both the primary cohort (AUC = 0.962) and the independent validation cohort (AUC = 0.842). The CDLMCE-CT model achieved good predictive performance in both the primary cohort (AUC = 0.842) and the independent validation cohort (AUC = 0.736).
To use this model, users only need to feed the region of interest (ROI) of the tumor MR or CT image and corresponding clinical factors into the model. The CDLM will give the MVI probability for the patient and highlight the suspicious tumor region that are most related to MVI status, which is very easy to use in application.